About: Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on January 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в січні 2009 (uk) مقالة علمية نشرت في يناير 2009 (ar) գիտական հոդված հրատարակված 2009 թվականի հունվարին (hy) scientific article published on January 2009 (en)
publication date	wds:Q37369407-B93DD9FB-626C-454D-9737-9E682D2C8440
publication date	2009-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q37369407-56A449EB-EA3C-4A1E-83C7-5C1CF890B19A wds:Q37369407-7E082DC8-F2A1-40BA-BD82-E5DF6FD919EA wds:Q37369407-FFF970EC-E7F8-489B-BDD5-1119216D0725
author name string	Laurence J N Cooper Michael A Pulsipher Peter Bader
rdfs:label	Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (en) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (nl) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (ast)
skos:prefLabel	Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (en) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (nl) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (ast)
name	Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (en) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (nl) Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (ast)
author	wds:Q37369407-BE609772-E5B2-492D-AF75-0901D34C5A92
author	Thomas Klingebiel
title	wds:Q37369407-01C86A7D-6C8B-4C26-8504-D8FC4BDF1D5D
title	Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse (en)
page(s)	wds:Q37369407-46F45373-330D-4481-89CB-6949CFD949C8
page(s)	62-71
instance of	wds:Q37369407-18347266-309A-43DA-B435-356A6CAEBCC0 wds:Q37369407-afb33e6c-ecbe-4b24-acf1-e569bb7bcbf3
instance of	review article scholarly article
main subject	wds:Q37369407-138EA63F-D86A-486A-AF53-FC1FA4E9393D wds:Q37369407-9910BC90-F03D-4515-9F12-6DED9D447527 wds:Q37369407-F7604EBD-E22F-4E4D-B90F-D85C6DCFEAEB
main subject	leukemia chemotherapy lymphoblastic leukemia
PubMed ID	wds:Q37369407-51BDF205-4E5C-4EED-9E1D-C37DC172A972
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19147081
PubMed ID	19147081
published in	wds:Q37369407-C32F2DA7-2E35-4420-8FC5-E8A722E88CCE
published in	Biology of Blood and Marrow Transplantation
issue	wds:Q37369407-8BF4101B-90FE-4D65-AF67-D098C557F5D1
volume	wds:Q37369407-0E6BCB74-6593-4556-9F13-AC16314574B5
issue	1 Suppl
volume	15
DOI	wds:Q37369407-1BABBA0E-C7AB-4978-A3FD-791997765B8E
DOI	http://dx.doi.org/10.1016/J.BBMT.2008.11.009
DOI	10.1016/J.BBMT.2008.11.009
ResearchGate publication ID	wds:Q37369407-E28FBA24-1551-421D-8EFD-80F68F482846
ResearchGate publication ID	23952125
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37369407
is cites work of	Exogenous endothelial cells as accelerators of hematopoietic reconstitution Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL). High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant? NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia Cellular therapy following allogeneic stem-cell transplantation Feasibility of treating post-transplantation minimal residual disease in children with acute leukemia. Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia. Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD). Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL. How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment Excellent outcomes for patients with B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand × Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-Resistant B-Precursor Acute Lymphoblastic Leukemia in Mice Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice Detection of relapse after hematopoietic stem cell transplantation in childhood by monitoring of WT1 expression and chimerism.
is cites work of	wds:Q33924570-A8D6896D-D826-47E8-86DC-F6C5FD6EC3C4 wds:Q89455205-46FAD01B-4760-4EE3-BF5C-91FB73BD9634 wds:Q38079288-88415999-DAE6-443F-84E5-C157977CC7E3 wds:Q33937843-B01965F0-C8F5-461B-AE97-A1090A09535D wds:Q35100974-29A89E57-143C-4F54-83B4-AC78DA3A8CAF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software